Dr Simon Tsoi investigated the association between body weight and tocilizumab effectiveness in rheumatoid arthritis, using data from the BSRBR-RA study. The results were published in the Rheumatology journal. What was already known?Tocilizumab is a type of treatment...
Category: Rheumatoid Arthritis
Tyenne (tocilizumab) – the new biosimilar on the block
What is Tyenne? Tyenne is the first tocilizumab (interleukin-6) biosimilar that has recently been approved by the European Medicines Agency (EMA) for the treatment of moderate to severe rheumatoid arthritis in adults. It is now starting to be prescribed in the UK and...
Recent Comments